Identification of distant metastases with PET‐CT in patients with suspected recurrent head and neck cancer
- 9 February 2009
- journal article
- research article
- Published by Wiley in The Laryngoscope
- Vol. 119 (4), 703-706
- https://doi.org/10.1002/lary.20118
Abstract
Objectives: To investigate the utility of positron-emission tomography/computed tomography (PET-CT) in identifying distant metastatic disease in patients with suspected recurrent head and neck squamous cell cancer (HNSCC). Study Design: Retrospective analysis. Methods: Retrospective analysis of 64 consecutive patients with suspected recurrent HNSCC following definitive treatment who underwent PET-CT imaging were eligible for inclusion. Patients with previous known distant metastatic disease were excluded. Results: The majority of patients (81%) had TNM stage III or IV disease. PET-CT was suspicious for pulmonary malignancy in 14 patients (22%) and indeterminate in 6 patients (9%). Pulmonary metastases or a new lung primary were present in 10 patients (16%): 7 of 14 patients with positive PET-CT scans (50%) and 3 of 50 patients with negative or indeterminate PET-CT scans (6%). Including nonpulmonary sites, the overall incidence of distant disease was 23% (15/64) with 20% (13/64) unsuspected prior to PET-CT. The sensitivity and specificity of PET-CT in predicting distant malignancy was 86% and 84%, respectively, with a positive predictive value of 60% and a negative predictive value of 95%. There was a significant correlation between standardized uptake value (SUV) on PET-CT and positive histology, with a mean SUV of 8.5 (range, 4.7–16.2) in patients with distant metastases compared with a mean SUV of 2.9 (range, 1.9–4.2) in patients with benign pathology (r = 0.87, P < .0001). Conclusions: A significant number of patients with recurrent HNSCC have distant metastases at the time of recurrence. These data suggest that PET-CT improves detection of metastatic disease in the high-risk patient and should be performed as part of the routine evaluation of patients with suspected recurrence prior to salvage surgery. Laryngoscope, 2009Keywords
This publication has 19 references indexed in Scilit:
- Outcomes of Patients with N3 Neck Nodes Treated with ChemoradiationThe Laryngoscope, 2008
- Screening for distant metastases in head and neck cancer patients by chest CT or whole body FDG-PET: A prospective multicenter trialRadiotherapy and Oncology, 2008
- Identification of Distant Metastases With Positron–Emission Tomography‐Computed Tomography in Patients With Previously Untreated Head and Neck CancerThe Laryngoscope, 2008
- Impact of [18F]‐2‐Fluorodeoxyglucose–Positron Emission Tomography/Computed Tomography on Previously Untreated Head and Neck Cancer PatientsThe Laryngoscope, 2007
- Screening for distant metastases in patients with head and neck cancer: Is there a role for 18FDG-PET?Oral Oncology, 2006
- Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography Imaging in Patients with Carcinoma of the Larynx: Diagnostic Accuracy and Impact on Clinical ManagementThe Laryngoscope, 2006
- Salvage surgery after failure of very accelerated radiotherapy in advanced head-and-neck squamous cell carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 2005
- Delayed Regional Metastases, Distant Metastases, and Second Primary Malignancies in Squamous Cell Carcinomas of the Larynx and HypopharynxThe Laryngoscope, 2001
- Salvage Surgery for Patients With Recurrent Squamous Cell Carcinoma of the Upper Aerodigestive Tract: When Do the Ends Justify the Means?The Laryngoscope, 2000
- Monitoring of Response to Radiotherapy with Fluorine-18 Deoxyglucose PET of Head and Neck Squamous Cell CarcinomasActa Oto-Laryngologica, 1998